RPS calls for pharmacy students to be included in NHS bursary scheme In response to a Welsh government consultation, the Royal Pharmaceutical Society said pharmacy students should be eligible for the NHS Wales bursary scheme since “the nature of pharmacy education has evolved significantly”.…
The Pharmaceutical Journal’s Siobhan Chan awarded ‘Newcomer of the Year’ This is the fourth year in a row that a journalist from The Pharmaceutical Journal has been recognised at the Avicenna Media Awards.…
Class 1 recall issued for quetiapine oral suspension A national patient safety alert said that pharmacy teams must immediately stop supplying affected products, as well as quarantine and return any remaining stock.…
Tobacco companies should fund national community pharmacy ‘stop smoking’ service, says report Recommendations by AstraZeneca in partnership with several pharmacy bodies have also called for the ‘NHS health check’ to be offered in community pharmacies.…
Prescribing error led to death of baby, says coroner A newborn patient was wrongly prescribed sodium acid phosphate instead of sodium chloride, leading to an overdose, a report from the coroner for Inner West London found.…
Health news round-up: NICE approvals, surveillance data and GLP-1 warnings A weekly summary of important developments in pharmacy and health news that you may have missed.…
Managing neuropathic pain in bipolar disorder An overview of the clinical considerations for managing comorbid bipolar disorder and neuropathic pain.…
PJ view: Access to rare disease treatment should not be a rarity Policymakers and healthcare leaders must persevere with long overdue changes to improve access to treatments for rare diseases.…
NHS prepayment certificates may have saved patients nearly £500m in prescription costs The NHS Business Services Authority's experimental analysis of data from 2024/2025 also revealed that prescriptions could have cost patients more than £800m in charges if they did not use a prepayment certificate.…
Is a cure for epidermolysis bullosa on the horizon? New trials to repurpose drugs for the rare genetic skin condition epidermolysis bullosa are offering families a level of hope not seen before, raising the question of whether a cure may finally be in sight.…
